Procter & Gamble (PG) Q4 2025 10-Q Quarterly Report
Filed: Jan 23, 2026Period ending Dec 31, 2025
Health Care
Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsSEC EDGAR Procter & Gamble (PG) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Jan 23, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Procter & Gamble Q4 2025 10-Q Analysis
Management Discussion & Analysis
- • Quarterly revenue $22.2B, up 1% YoY from $21.9B; organic sales flat excluding acquisitions/divestitures and FX
- • Operating margin 24.2% vs 26.2% YoY; net earnings margin 19.4% vs 21.2%; net earnings down 7% to $4.3B; diluted EPS $1.78 vs $1.88 (-5%)
- • Best segment: Beauty sales up 5% ($4.0B); worst: Baby, Feminine & Family Care sales down 3% ($5.1B) and net earnings down 9% ($1.0B)
- • Operating cash flow $10.4B YTD, adjusted free cash flow $8.7B, free cash flow productivity 95%; CapEx $2.4B contributing to $2.8B investing cash outflow
- • Management expects $1.5-$2.0B restructuring costs over 2 years; notes risks from FX volatility, tariffs, competitive pressures, and macro uncertainties impacting near-term results
Risk Factors
- • No new or changed risk factors reported this quarter versus the fiscal 2025 10-K
- • Continuing supply chain disruptions risk impacting raw material availability and production costs
- • Ongoing compliance risk with global regulations on product safety and sustainability standards
- • Intense competitive pressure from private label brands affecting market share and pricing power
- • Currency exchange rate volatility risk, especially exposure to euro and emerging market currencies
Procter & Gamble Q4 2025 Quarterly FinancialsXBRL
Revenue
$22.2B
▲ +1.5% YoY▼ -0.8% QoQ
Net Income
$4.3B
▼ -6.7% YoY▼ -9.1% QoQ
Net Margin
19.5%
▼ -171bp YoY▼ -177bp QoQ
Source: XBRL data from Procter & Gamble Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Procter & Gamble
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.